HIV resistance

View All

HIV-Therapeutics-Market-drugs-companies-epidemiology-population
Top Drugs To Watch in HIV (2025)

Human Immunodeficiency Virus or HIV is a species of Lentivirus (genus of retrovirus) that attacks the body’s immune system and obstructs the body’s ability to fight outer infections. The virus can be transmitted when contacted with infected blood, semen or vaginal fluids. HIV attacks the immune cells of the body ma...

Find More

Curing HIV with gene therapy
In a blind race to cure HIV, can Gene therapy be a deal-breaker?

HIV infection has become a global health burden, has claimed over 32 million lives so far since the very first case of AIDS was reported in 1981. According to a report put forward by the WHO, HIV prevalence was reported to be around 37.9million by the end of 2018.  However, HIV has grown to pandemic proport...

Find More

HIV treatment landscape
HIV Treatment Landscape and A New Approach

The Human immunodeficiency virus (HIV) cases have grown to pandemic extents since the first case of acquired immunodeficiency syndrome (AIDS) was reported in 1981. CDC estimates that approximately 1.1 million people in the U.S. are living with HIV today. About 15 per cent of them (1 in 7) are unaware of their infec...

Find More

HIV-Drug Resistance
Frightening Surge in HIV-drug Resistance: The Biggest Challenge Ahead

In a survey conducted by WHO, globally, 37.9 million people were tested positively living with HIV in 2018. Out of which, 62% (23.3 million) of the people were receiving antiretroviral treatment by the end of 2018. WHO, in addition to all the other Health organizations are working towards achieving the WHO/UNAIDS 9...

Find More